CAS: 10316-79-7; 1-Amino-1-Cyclopentanemethanol

该化合物是有机化合物,其特点是有氨基氨基化合物和一个与环戊烷环相连的氢氧化甲基化合物.该化合物的特点是五人碳环,有助于其循环结构,氨基氨基乙醇组提供了基本特性,允许其参与各种化学反应,包括核生殖替代.氢氧化甲基组在极溶剂中强化溶性,并能够参与氢结合,影响其再活动以及与生物系统的互动.这些功能组的存在表明,在药用化学中,特别是在药物的开发中,这种结构可以模仿天然化合物或作为合成途径的中间体.此外,该化合物的立体化学学学在其生物活动中可以发挥重要作用,使其在与药物设计和开发有关的研究中成为感兴趣的一个主题.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

ethyl 1-amin°Cyclopentanecarboxylate 1-azido-1-hydroxymethylcyclopentane 1-amino-1-cyclopentanecarboxylic acid 1-oxaspiro[2.4]heptane-1-cyclopentanmethanol1(6-Chlor-5-nitro-4-pyrimidinyl)amino-1-cyclopentanmethanol -1,1'-dicyclopentanmethanol1,1'-(5-Nitro-4,6-pyrimidindiyl)diamino-1,1'-dicyclopentanmethanol 7-Benzyl-2-(1-hydroxymethyl-cyclopentylamino)-1-methyl-1,7-dihydro-purin-6-one 7-Benzyl-2-(1-hydroxymethyl-cyclopentylamino)-1-methyl-8-phenyl-1,7-dihydro-purin-6-one

合成工艺路线路线简述

    环亮氨酸置于氯化亚砜,红铝体系中,用 甲苯 用作溶剂,化学反应 2.0H,反应生成1-氨基-1-环戊基甲醇
    参考文献:用于生物筛选的fsp 3-富双螺旋基复合文库的设计与合成
    标题:用于生物筛选的fsp 3-富双螺旋基复合文库的设计与合成
    摘要:探索创新的化学空间是药物发现早期阶段的关键步骤.双螺环骨架存在于天然产物和其他生物学相关的代谢物中,并显示出诱人的特征,例如分子致密性,结构复杂性和三维特征.已经开发了一种简单的合成双螺环化合物库的方法,该方法从容易获得的市售试剂和稳健的化学转化开始.介绍了许多在欧洲铅工厂项目中实施的新型双螺环支架实例.
    Doi:10.1021/acscombsci.6B00005

    海关参考信息

    专利信息


    专利号:US-9950988-B2
    优先权日:2012-12-26
    标题:Method for the synthesis of alpha/alpha-prime-alcoxylated glycerol linear carbonic esters
    发明人:LEISING FRéDéRIC; MOULOUNGUI ZéPHIRIN
    权利人:CHRYSO; INST NAT POLYTECHNIQUE TOULOUSE; INST NAT DE LA RECH AGRONOMIQUE INRA
    摘要:A method for the synthesis of α/α′-alcoxylated glycerol linear carbonic esters, wherein the following are brought into contact at a reaction temperature lower than 220° C.: a quantity of at least one precursor selected from the group consisting of α/α′-alcoxylated glycerol cyclo-carbonates; a quantity of at least one catalyst selected from the group consisting of metal oxides, Lewis acids, organometallic catalysts and mineral bases; and a quantity of at least one organic primer. A composition containing at least one novel α/α′-alkoxylated glycerol linear carbonic ester.

    专利号:US-2005192265-A1
    优先权日:2003-03-20
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:THOMPSON RICHARD C; WILKIE STEPHEN; STACK DOUGLAS R; VANMETER ELDON E; SHI QING; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; HENRY STEVEN S; MCDANIEL STACEY L; STUCKY RUSSELL D; PORTER WARREN J
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:US-6906056-B2
    优先权日:1998-06-22
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:THOMPSON RICHARD C; WILKIE STEPHEN; STACK DOUGLAS R; VANMETER ELDON E; SHI QING; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; HENRY STEVEN S; MCDANIEL STACEY L; STUCKY RUSSELL D; PORTER WARREN J
    权利人:LILLY CO ELI
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:US-2015329468-A1
    优先权日:2012-12-26
    标题 :Method for the synthesis of alpha/alpha-prime-alcoxylated glycerol linear carbonic esters

    专利号:US-6660832-B1
    优先权日:1999-08-20
    标题:Macrocyclic compounds and preparation methods thereof
    发明人:JEFFERSON ELIZABETH; SWAYZE ERIC EDWARD
    权利人:ISIS PHARMACEUTICALS INC
    摘要:The present invention is directed to macrocyclic compounds of the formula (I)wherein Q, X, R1 and R5 are as defined herein. Compounds of the invention are useful for therapeutic and prophylactic treatment of bacterial infection in mammals. Solid phase synthetic procedures are provided effecting synthesis of the macrocyclic rings attached to a solid support.

    专利号:US-5104947-A
    优先权日:1989-08-07
    标 题:Polyphosphazenes and their synthesis
    发明人:SCHACHT ETIENNE; CROMMEN JAN
    权利人:ETHYL CORP
    摘要:Described are polyphosphazenes which may be represented by the general formula ##STR1## in which R is a hydroxy-substituted or protected hydroxy-substituted saturated aliphatic group, R' is a hydrocarbyl group, R' is a residue of an alpha amino acid, n is from about 50 to about 25,000, and x is a number averaging from 0.05 to 1.00 per repeating unit and y is a number averaging from 0.95 to 0.00 per repeating unit so that per repeating unit the sum of x and y is 1. Removal of the protecting group in the R moiety renders the polymers water soluble. The polymers have a controllable set of properties including degree of hydrolytic stability, permeability, hydrophilicity, and bioacceptability. They may be used in the production of hydrogels for drug release systems, plasma extenders, and biomedical implants.
    上海西浦化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.sheepchem.com
    企业联系电话:021-67157650;021-67677883👤
    📞上海西浦化工有限公司 ⚠️参考联系方式
    联系人:秦勇;陈悦
    电话:021-67157650;021-67677883
    手机:18918267570;18019321192
    传真:021-67157651
    邮箱:sheepchem@163.com
    通信地址: 上海市松江区曹农路255号 5号楼
    邮编: 201401
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海市松江区曹农路255号 5号楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Paul V Fish, Et Al. Selective Urokinase-Type Plasminogen Activator Inhibitors. 4. 1-(7-Sulfonamidoisoquinolinyl)Guanidines. J Med Chem. 2007 May 17;50(10):2341-51.

    合成参考文献


    摘要:Chimica Therapeutica., 4(136), 1969
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知